Structure‐Guided Development of Chemically Tailored Peptide Binders of RNF43/ZNRF3 to Enable Versatile Design of Membrane Protein‐Targeting PROTACs
Angewandte Chemie International Edition · 2025-05 · 64 (19)
DOI: 10.1002/anie.202501488 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 20.03.2025. Verfasst von Jibin Cui und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Translational Medicine, School of Pharmacy, School of Biomedical Engineering, Shanghai Key Laboratory for Antibody-Drug Conjugates with …. Hauptthemen laut MEDLINE: Peptides, Ubiquitin-Protein Ligases, Membrane Proteins. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Foundation of Muyuan Laboratory.
Abstract (Originalsprache)
Targeted membrane protein degradation using cell surface E3 ligases RNF43/ZNRF3 via proteolysis targeting chimeras (PROTACs) represents an effective strategy for treating membrane drug targets that cannot be fully inhibited using traditional inhibitors. Several ingenious chimeras have been developed to tether RNF43/ZNRF3 to target membrane proteins, resulting in the degradation of targets at sub‐nanomolar concentrations both in vitro and in vivo. However, currently available RNF43/ZNRF3 binders are genetically encoded and have poor plasticity, which limits the design and promotion of such PROTACs. Here, we exploited the AlphaFold‐predicted complex structures of ligand‐bound RNF43/ZNRF3 and developed a class of chemically tailored peptide binders for ZNRF3/RNF43. With these peptide binders that can be conveniently prepared by de novo peptide synthesis, we established a new membrane protein degradation platform that allows versatile modular design and targeted degradation of clinically relevant membrane proteins, i.e., PD‐L1 and EGFR. This study presents a new subtype within the PROTAC field to develop therapeutic peptides targeting membrane proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Translational Medicine, School of Pharmacy, School of Biomedical Engineering, Shanghai Key Laboratory for Antibody-Drug Conjugates with Innovative Target, Shanghai Jiao Tong University, Shanghai, 200240, Ch…
- Center for Future Foods, Muyuan Laboratory, 110 Shangding, Road, Zhengzhou, Henan Province, 450016, China.
Förderung
- National Natural Science Foundation of China
- National Key R&D Program of China
- Foundation of Muyuan Laboratory
- Shanghai Rising-Star Program
- Shanghai Pilot Program for Basic Research-Shanghai Jiao Tong University
- Fundamental Research Funds for the Central Universities
- Shanghai Jiao Tong University 2030 Initiative
- Chenguang Program of Shanghai Education Development Foundation
Zitieren
APA
Cui, J., Zheng, Q., Weng, Y., Zhai, X., Su, Z., Du, Y., Wei, X., Yu, Y., Qu, Q., & Pan, M. (2025). Structure‐Guided Development of Chemically Tailored Peptide Binders of RNF43/ZNRF3 to Enable Versatile Design of Membrane Protein‐Targeting PROTACs. Angewandte Chemie International Edition, 64(19). https://doi.org/10.1002/anie.202501488
Vancouver
Cui J, Zheng Q, Weng Y, Zhai X, Su Z, Du Y, et al. Structure‐Guided Development of Chemically Tailored Peptide Binders of RNF43/ZNRF3 to Enable Versatile Design of Membrane Protein‐Targeting PROTACs. Angewandte Chemie International Edition. 2025;64(19). doi:10.1002/anie.202501488
BibTeX
@article{Cui2025,
author = {Cui, Jibin and Zheng, Qingyun and Weng, Yicheng and Zhai, Xiaoguo and Su, Zhen and Du, Yunxiang and Wei, Xiaoxiong and Yu, Yuanyuan and Qu, Qian and Pan, Man},
title = {Structure‐Guided Development of Chemically Tailored Peptide Binders of RNF43/ZNRF3 to Enable Versatile Design of Membrane Protein‐Targeting PROTACs},
journal = {Angewandte Chemie International Edition},
year = {2025},
volume = {64},
number = {19},
doi = {10.1002/anie.202501488}
}
EUVIMED